Covered recipient · General Payments record
ROXANNE SWAFFORD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,516.47
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $497.62 | 17 |
| Education | $8.45 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| LEO Pharma Inc. | $163.68 | 4 |
| ABBVIE INC. | $141.61 | 6 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $57.87 | 2 |
| Lilly USA, LLC | $47.56 | 2 |
| GENZYME CORPORATION | $33.69 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $23.98 | 1 |
| Regeneron Healthcare Solutions, Inc. | $23.16 | 1 |
| Galderma Laboratories, L.P. | $14.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $4.29 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108276156 | CMS |
| ABBVIE INC. | $8.45 | 03/20/2024 | Education | Undisputed | 01/23/2026 | 1108276158 | CMS |
| ABBVIE INC. | $109.01 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108276160 | CMS |
| ABBVIE INC. | $3.88 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108276162 | CMS |
| ABBVIE INC. | $11.18 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108276164 | CMS |
| ABBVIE INC. | $4.80 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108276166 | CMS |
| Galderma Laboratories, L.P. | $14.52 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145395233 | CMS |
| GENZYME CORPORATION | $33.69 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139816937 | CMS |
| LEO Pharma Inc. | $26.79 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152690553 | CMS |
| LEO Pharma Inc. | $32.77 | 09/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152690555 | CMS |
| LEO Pharma Inc. | $21.76 | 09/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152690557 | CMS |
| LEO Pharma Inc. | $82.36 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152690559 | CMS |
| Lilly USA, LLC | $25.26 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135938848 | CMS |
| Lilly USA, LLC | $22.30 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135883249 | CMS |
| Novartis Pharmaceuticals Corporation | $23.98 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087163295 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.16 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114379293 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $34.76 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152271615 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $23.11 | 06/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152271619 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.